The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2020 | NCRI Lung Cancer Study Group: clinical trials
Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, University of Sheffield, Sheffield, UK, outlines the role of the National Cancer Research Institute (NCRI) Lung Cancer Study Group in the management and maintenance of clinical trials in the UK. He highlights the focus on testing combinations of new drugs and radiotherapy, palliative radiotherapy, and the living with and beyond cancer initiative. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
